Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
General Radiation Oncology
Is there an increased risk of spinal cord myelopathy in patients who have heterozygous ATM mutations?
Can bone mets in the vertebral body be treated with radiation in patients with ATM mutations?
Related Questions
How would you approach a young patient with stage I follicular lymphoma of the mesenteric lymph nodes?
How would you manage an endometrial adeno abdominal wall recurrence at the port site from prior laparoscopic surgery?
How would you approach a patient with stage I gastric MALT who achieved a complete response to chemoimmunotherapy after only 2 cycles?
Are there any clinical scenarios that you feel should be characterized as radiation oncology emergencies which are not currently?
When would you consider adjuvant radiation therapy for tenosynovial giant cell tumors of the extremity?
What dose and setup would be recommended for isolated penile shaft metastasis from bladder cancer?
What are your shift tolerances for fractionated SBRT and SRS treatments?
Do you use a liver dose constraint for right-sided breast cancer?
Is Hyper IGE syndrome a contraindication for radiation therapy?
Is prior whole brain radiation and/or spinal radiation within last 6 months a contraindication for intrathecal methotrexate treatment in with leptomeningeal disease?